Former Interim Chief Executive Officer, President and Chief Operating Officer · KALA BIO, Inc. (KALA)

Todd Bazemore

A named executive officer of KALA BIO in every fiscal year CompBrief holds from FY2018 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$3,476,972

Salary $489,112Stock awards $76,053Bonus $585,450

FY2024: $949,550

1st of 4 named executive officers at Kala BIO by FY2025 total.

4 named officers on file for KALA BIO, FY2025

Todd Bazemore’s pay file — $29

  • 8 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how KALA BIO’s whole pay program stands against its peers

  • KALA BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KALA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed September 24, 2026 (DEF 14A).

Free

Get Todd Bazemore’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Todd Bazemore compensation by year

KALA BIO Summary Compensation Table · all 8 fiscal years held
In US dollars, as KALA BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$405,000$440,300$455,700$489,878$515,000$535,600$535,600$489,112
Bonus$194,400$158,508$273,420$171,457$257,500$187,460$187,460$585,450
Stock awards$0$0$1,170,000$188,650$0$1,378,219$45,500$76,053
Option awards$233,108$1,066,604$318,777$483,131$242,777$831,857$171,543$2,262,211
Non-equity incentive$0$0$0$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0
All other$12,950$8,694$10,419$10,240$10,540$10,520$9,447$64,146
Total$845,458$1,674,106$2,228,316$1,343,356$1,025,817$2,943,656$949,550$3,476,972

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KALA BIO, Inc. DEF 14A filed September 24, 2026, accession 0001829126-26-010384, and prior-year filings. Open the filing on EDGAR.

How this page was built: the KALA BIO, Inc. filed document, accession 0001829126-26-010384. Every figure is read from that document and cited to the page and table it appears in. Filed September 24, 2026.

$845K
$1.7M
$2.2M
$1.3M
$1.0M
$2.9M
$950K
$3.5M
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU16,236$9,027—
RSU10,100$5,616—
RSU4,334$2,410—
RSU4,268$2,373—
RSU794$441—
Option34,842—$7.53
Option165,000—$11.22
Option15,260—$7.00
Option24,349—$14.56
Option7,533—$7.05

Per the Outstanding Equity Awards at Fiscal Year-End table in KALA BIO, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

KALA BIO’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Todd Bazemore · this pageFormer Interim Chief Executive Officer, President and Chief Operating Officer$3,476,972
Kim BrazzellFormer Head of Research and Development and Chief Medical Officer$1,358,174
Mary ReumuthFormer Chief Financial Officer$1,322,608
Mark IwickiFormer Chief Executive Officer$906,642

The full KALA BIO compensation record

free company brief

This page is one person within KALA BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are KALA BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Todd Bazemore's compensation dossier · One-time report. No refunds.